Bayer initiates first-in-human study of BAY-2666605 in metastatic melanoma and advanced solid tumors April 26, 2021
Vivet opens enrollment in phase I/II study of VTX-801 gene therapy for Wilson's disease April 26, 2021
Neurodevelopmental and biomarker data for RGX-121 in a phase I/II study for severe MPS II April 26, 2021
Zyesami and Veklury studied within new ACTIV-3 Critical Care study for severe COVID-19 April 26, 2021
Phase III MELODY study of nirsevimab to prevent RSV infection in infants meets primary endpoint April 26, 2021
RSS